answer:

<ul> <li>Intraneuron is changing how we identify mild cognitive impairment, dementia, and Alzheimer's disease. Because there are not enough neurologists and many doctors do not screen elderly patients, we are offering an affordable, easy-to-use solution. Our special screening software uses speech recognition to give quick results, making it easier for patients and doctors alike. By catching declines in thinking earlier, we can reduce the huge financial burden of mild cognitive impairment and dementia.</li> <li>The Intraneuron Memory Exam is based on the well-respected field of neuropsychology. We use cognitive testing, speech recognition, speech synthesis, and machine learning to detect cognitive decline early on.</li> </ul>